Supreme Court Doesn't Bite On Amarin Appeal In Omega-3 Fair Trade Complaint
Executive Summary
The court included its decision on Amarin’s ’s petition for a writ of certiorari among the single-line denials of nearly 200 appeals to consider decisions in civil litigation and convictions in criminal cases. However, Amarin still eyes curbing competition from omega-3 supplements.
You may also be interested in...
Statin Drug Makes SPORT Of Supplements In Pharma-Funded, 28-Day Trial On Lowering LDL
Primary and secondary endpoint results in “Supplements, Placebo, or Rosuvastatin” study conducted by Cleveland Clinic include no difference, after four weeks, in total cholesterol and blood triglyceride measures between subjects receiving placebo and those using fish oil, cinnamon, garlic, turmeric, plant sterols or red yeast rice.
US Fish Oil Supplement Export Certification Program Continued 90 Days With Home TBD
NOAA Seafood Inspections Program had planned 1 May end to export certifications for fish oil supplements before granting 90-day extension as it talks with FDA about administering the program.
US Omega-3 Supplement Firm Changes Claims On Amarin Challenge, But Not Label Or Company Name
National Advertising Division, in rare review of an Rx drug firm’s challenge of supplement ad claims, reported Innovix Pharma pulled health claims for OmegaVia brand supplements challenged by Amarin. Innovix prevailed in defending its labeling as accurate and its name as not false advertising.